Searched for
PHARMACEUTICAL DISTRIBUTORS
Global creditors drag Udaan's parent to bankruptcy court in Singapore after $170-million bond defaultInsolvency petition filed this week, A&M appointed as liquidator of B2B commerce company. Ten year old co has seen valuations crash 70% as ...- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
- Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...
- Texas emerges as US' new economic powerhouse amid California exodusHouston, Texas is leading corporate headquarters relocations, attracting 192 companies since 2018. Businesses are leaving California due to...
- Bio Medica Laboratories IPO: Check GMP, price band, subscription and other detailsBio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...
- Rising input costs, export slump take a toll on drug companies' healthAccording to industry executives, the modest price hike of 0.6% that the government has allowed on essential medicines effective April 1 is...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- Supreme Court upholds NPPA's Rs 4.65 cr recovery from Sun Pharma for drug price violationThe Supreme Court upheld NPPA's Rs 4.65 crore recovery from Sun Pharma for Roscilox overpricing (April 1996 - July 2003). The appeal was re...
- Ozempic frenzy lures rich Indians to brave the gray marketPeople are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying coun...
- Jammu pharmaceutical distributors urge Prime Minister Modi to pass directions on MRP"The larger mandate of the NPPA was to seal the MRP keeping in view the margins allowed under the Drug Price Control Order to the wholesale...
- CCI imposes Rs 74 cr fine on Himalaya Drug, 3 others for anti-competitive trade practicesBoth the drug associations and pharma companies responsible for mandating the requirement of obtaining NOC prior to the appointment
- Ahead of GST, drug inventories cutStockists, worried they may suffer losses on account of a possible mismatch between tax payouts and tax refunds once GST kicks in, have sta...
- Govt committee set to study steep trade margins on medicine brandsA committee set up under the department of pharmaceuticals will study the extent of margins on medicine brands that are supplied to traders...
- Pharma consolidation in US hurts mid-sized Indian drug makersSeveral mid-sized Indian drug makers heavily dependent on the United States are beginning to suffer because consolidation in the US pharmac...
- Drug companies, traders to calculate loss due to new pricing policyPharmaceutical companies and distributors have decided to calculate “loss to trade channels” on account of the new pricing policy.
Load More
